TuHURA Biosciences, Inc. (HURA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$2.10$0.00 (0.00%) on the dayAs of the close; data may be delayed.
HURA price, last 12 months
Key stats
- Previous close
- $2.10
- Open
- $2.14
- Day range
- $2.05 – $2.15
- 52-week range
- $0.4100 – $3.43
- Volume
- 149.3K
- Avg volume (20 days)
- 188.4K
- Market cap
- $133.8M
Performance
1W0.0%
1M−1.4%
3M−2.8%
6M+7.7%
YTD+177.5%
1Y−18.3%
vs S&P 500, 1Y−35.1 pts
Technicals and fundamentals
About TuHURA Biosciences, Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $133.8M